NOAH website
Compendium home page
Introduction
Presentation
Uses
Dosage and administration
Contra-indications, warnings, etc
Pharmaceutical precautions
Legal category
Packaging Quantities
Further information
Marketing authorisation number
Significant Changes
You are here:
Introduction
> Significant Changes
Baycox Bovis 50 mg/ml oral suspension: Significant Changes
Baycox Bovis 50 mg/ml oral suspension
Significant Changes
Date updated: 26 September 2007
Powered by the Librios Semantic Environment
Baycox Bovis 50 mg/ml oral suspension: Significant Changes
Date updated: 26 September 2007